Electrocardiogram (ECG/EKG): Procedure, Types & What Results Mean — Cost, Top Hospitals & Success Rates | MyMedicPlus

An electrocardiogram (ECG or EKG) — from the Greek elektro (electricity), kardia (heart), and gramma (writing) — is the single most widely used cardiac diagnostic test in the world. It captures the heart's electrical signals as a continuous waveform, allowing clinicians to assess rate, rhythm, conduction pathways, and the functional integrity of each cardiac chamber in under ten minutes.

The test works by detecting tiny voltage differences on the skin's surface created each time the heart muscle depolarises and repolarises. Adhesive electrode pads placed on the chest, arms, and legs feed these signals into an ECG machine that converts them into the characteristic P-QRS-T waveform printed on graph paper or displayed digitally. Each deflection corresponds to a specific electrical event: the P wave represents atrial depolarisation, the QRS complex reflects ventricular depolarisation, and the T wave marks ventricular repolarisation.

First developed by Willem Einthoven in 1902 — earning him the Nobel Prize in Physiology or Medicine in 1924 — the ECG has evolved from a bulky galvanometer into a lightweight, portable device capable of transmitting results via smartphone. Modern 12-lead ECG systems simultaneously record electrical activity from twelve distinct angles, providing a three-dimensional electrical map of the heart that supports nuanced diagnostic interpretation.

The procedure is completely painless, requires no needles, no radiation, and no special preparation beyond remaining still for a few seconds. Results are available within minutes, making the ECG indispensable in emergency rooms, outpatient clinics, pre-operative suites, and routine health screenings worldwide.

The ECG's diagnostic reach extends across virtually every category of heart disease. It is the first-line investigation for any patient presenting with chest pain, palpitations, dizziness, syncope, or breathlessness — symptoms that may signify life-threatening pathology.

• Acute Myocardial Infarction (Heart Attack): ST-segment elevation in specific lead groups pinpoints the affected coronary artery territory and guides emergency reperfusion decisions within minutes of patient arrival.
• Arrhythmias: Atrial fibrillation, atrial flutter, supraventricular tachycardia (SVT), ventricular tachycardia, ventricular fibrillation, and Wolff-Parkinson-White syndrome each produce pathognomonic ECG patterns identifiable at a glance.
• Heart Block: First-, second-, and third-degree atrioventricular (AV) block are graded by the PR interval duration and the relationship between P waves and QRS complexes, directly informing pacemaker decisions.
• Bundle Branch Blocks: Left and right bundle branch blocks indicate abnormal intraventricular conduction and may signal underlying structural disease or previous infarction.
• Electrolyte Imbalances: Hyperkalaemia produces peaked T waves and, at severe levels, a sine-wave pattern; hypokalaemia widens the QT interval; hypocalcaemia prolongs the ST segment.
• Cardiomyopathies: Hypertrophic cardiomyopathy causes characteristic deep septal Q waves and marked left ventricular hypertrophy voltages; dilated cardiomyopathy often shows poor R-wave progression.
• Pericarditis and Myocarditis: Diffuse saddle-shaped ST elevation with PR depression differentiates pericarditis from focal STEMI patterns.
• Drug Toxicity: QT-prolonging medications (antipsychotics, certain antibiotics, antiarrhythmics) are monitored via serial ECG to prevent torsades de pointes.

Beyond diagnosing acute illness, the ECG contributes to surgical risk stratification, sports cardiology pre-participation screening, and assessment of implanted pacemaker and defibrillator function.

Because the ECG is non-invasive, painless, inexpensive, and instantaneous, it carries virtually no contraindications. Almost any patient can undergo the test regardless of age, weight, or comorbidity.

Recommended indications include:

• Any chest discomfort, pressure, tightness, or radiation to the arm, jaw, or back
• Palpitations, irregular heartbeat, or awareness of a racing or skipping pulse
• Unexplained syncope (fainting) or pre-syncope (near-fainting)
• Dyspnoea (shortness of breath) of unexplained origin
• Pre-operative cardiac risk assessment before elective surgery
• Baseline cardiovascular evaluation for patients over 40 years of age
• Monitoring patients on QT-prolonging medications
• Athletes undergoing pre-participation screening for inherited channelopathies (long QT, Brugada, HCM)
• Patients with known hypertension, diabetes, or hyperlipidaemia — conditions that accelerate coronary artery disease
• Family history of sudden cardiac death before age 50

Special populations: Pregnant women may have a slightly leftward axis shift and sinus tachycardia as normal physiological adaptations; clinicians interpret results accordingly. Infants and children have distinct normal ranges for heart rate and QRS duration that differ from adults. Elderly patients may have left axis deviation, prolonged PR intervals, and bundle branch blocks as age-related changes without acute pathology.

The only practical limitation is that patients with severe skin conditions, extensive burns, or implanted spinal cord stimulators may require electrode repositioning or modified lead placement.

Several ECG modalities exist, each suited to different clinical questions. The cardiologist selects the appropriate type based on symptoms, suspected diagnosis, and duration of monitoring required.

• Standard 12-Lead ECG: The most common type, completed in 5–10 minutes in any clinic or hospital. Twelve leads provide simultaneous views of the heart from frontal (limb leads I, II, III, aVR, aVL, aVF) and horizontal (precordial leads V1–V6) planes. Ideal for acute presentations and baseline cardiovascular assessment.
• Holter Monitor (Ambulatory ECG): A portable recorder worn for 24–48 hours (extended to 7–14 days with patch monitors) while the patient continues normal activities. Captures intermittent arrhythmias that a resting ECG might miss. The patient keeps a symptom diary correlated with recorded events. Analysis software generates statistical arrhythmia summaries reviewed by a cardiologist.
• Exercise Stress ECG (Treadmill Test / Bruce Protocol): The patient walks on a treadmill at progressively increasing speed and incline while heart rate, blood pressure, symptoms, and 12-lead ECG are continuously monitored. ST-segment depression during exercise indicates myocardial ischaemia from coronary artery disease. Sensitivity is approximately 68% and specificity 77% for obstructive CAD.
• Event Recorder: A patient-activated device worn for weeks to months that records only when the patient presses a button during symptoms. Ideal for very infrequent palpitations.
• Implantable Loop Recorder (ILR): A matchstick-sized device implanted subcutaneously for up to 3 years. Reserved for unexplained syncope where all other investigations are non-diagnostic. Provides long-term continuous ECG with automatic arrhythmia detection.
• Signal-Averaged ECG (SAECG): A specialised resting ECG using computer averaging to detect late potentials — low-amplitude signals within the QRS complex predictive of ventricular tachycardia risk in post-MI patients.

The electrocardiogram offers a unique combination of clinical power, simplicity, and affordability that no other cardiac test replicates.

• Instantaneous Results: A 12-lead ECG is completed and interpreted in under 10 minutes, enabling life-saving decisions — such as activating a cardiac catheterisation laboratory for STEMI — within moments of patient arrival.
• No Radiation or Contrast: Unlike chest X-ray, CT coronary angiography, or nuclear stress testing, the ECG uses only tiny electrical measurements. It is completely safe for pregnant women, children, and patients with contrast allergies or renal impairment.
• Non-Invasive and Painless: No needles, no incisions, no discomfort beyond gentle electrode placement. The procedure causes no tissue damage and requires no recovery time.
• Extremely Cost-Effective: At $20–$150 for a standard 12-lead ECG, it is one of the most affordable diagnostic tools available, making it accessible in primary care, community clinics, and low-income healthcare settings globally.
• High Diagnostic Yield: A single 10-second recording can simultaneously diagnose or exclude atrial fibrillation, STEMI, heart block, and several electrolyte emergencies, guiding treatment for multiple conditions in one test.
• Baseline for Comparison: Serial ECGs over time allow clinicians to detect new ST changes, evolving conduction abnormalities, or response to antiarrhythmic therapy by comparison with prior tracings.
• Portable and Field-Deployable: Handheld single-lead ECG devices and smartwatch ECG apps bring cardiac monitoring to remote areas, home settings, and ambulance services, expanding early detection capacity.

When integrated with clinical history and physical examination, the ECG remains the foundation upon which all subsequent cardiac investigations — echocardiography, coronary angiography, cardiac MRI — are built.

The standard resting ECG carries no physiological risk to the patient. There is no electricity delivered to the body — the machine only measures signals, it does not generate them. Rare minor issues include:

• Skin Irritation: Adhesive electrode gel may cause mild, transient redness or itching in patients with sensitive skin or adhesive allergy. Hypoallergenic electrodes resolve this completely.
• False-Positive Results: ST-segment changes can occur due to early repolarisation (a benign variant common in young men), left ventricular hypertrophy, bundle branch block, or hyperventilation rather than true ischaemia — emphasising the need for clinical correlation.
• False-Negative Results: A normal resting ECG does not exclude coronary artery disease; approximately 50% of patients with stable angina have a normal resting ECG between episodes. Holter monitoring or stress testing may be required.
• Intermittent Arrhythmias Missed: Arrhythmias that occur only occasionally may not be captured on a 10-second resting ECG, necessitating prolonged ambulatory monitoring.
• Interpretation Variability: ECG interpretation requires training and experience. Computer-generated interpretations have a false-positive rate of approximately 6–7% and should always be reviewed by a qualified clinician.
• Electrode Placement Errors: Limb lead reversal or misplaced precordial electrodes produce systematic waveform changes that can mimic or mask pathology. Technician training and quality protocols minimise this risk.

For exercise stress ECG, there is a very small risk (approximately 1 per 10,000 tests) of serious cardiac event provoked by exertion. Resuscitation equipment and trained staff are mandatory during stress testing.

A resting 12-lead ECG requires no recovery and patients resume normal activities immediately after electrode removal. The interpretation and subsequent care pathway depend entirely on the findings.

If the ECG is normal: Symptoms may still require further evaluation. The cardiologist may order echocardiography, ambulatory Holter monitoring, or exercise stress testing depending on the clinical presentation. A normal ECG at rest does not exclude coronary artery disease or intermittent arrhythmia.

If acute STEMI is identified: Emergency activation of the cardiac catheterisation laboratory for primary percutaneous coronary intervention (PCI) occurs within minutes of diagnosis. Time-to-balloon under 90 minutes is the internationally accepted benchmark for STEMI care.

If a significant arrhythmia is found: Management depends on the specific arrhythmia. Atrial fibrillation prompts rate control, anticoagulation assessment (CHA2DS2-VASc scoring), and rhythm control planning. Ventricular tachycardia may require antiarrhythmic medication, catheter ablation, or implantable cardioverter-defibrillator (ICD) implantation.

If conduction abnormalities are detected: Third-degree heart block or symptomatic sick sinus syndrome typically leads to pacemaker implantation. New left bundle branch block in the context of chest pain is treated as STEMI equivalent.

Routine follow-up ECGs are scheduled at defined intervals for patients on antiarrhythmic drugs, those with implanted pacemakers or ICDs, and post-myocardial infarction patients to monitor recovery of left ventricular function and detect new arrhythmias.

The ECG is one of the most affordable diagnostic investigations in cardiology. Costs vary by ECG type, healthcare setting, country, and insurance coverage.

• Standard 12-Lead ECG: $20–$80 in outpatient clinics; $100–$150 in emergency department settings in high-income countries. In India, the cost ranges from ₹150–₹500 ($2–$6); in Thailand, $10–$30; in the UAE, $30–$80.
• Holter Monitor (24–48 hours): $200–$500 including device rental, recording, and cardiologist interpretation report. Extended 7–14 day patch monitors may cost $500–$1,200.
• Exercise Stress ECG: $150–$400 in most outpatient cardiology centres. Pharmacy-based or community cardiology providers in Southeast Asia offer stress tests for $50–$100.
• Event Recorder / ILR: Event recorders cost $300–$800 per month of rental. Implantable loop recorders carry a device and implantation cost of $2,000–$5,000 in the United States; significantly lower ($600–$1,500) in India, Mexico, or Turkey.

Insurance coverage: In most countries with public healthcare systems (UK NHS, Canada, Australia Medicare), ECG is fully covered for medically indicated requests. In the US, Medicare and most private insurers cover medically necessary ECGs; pre-operative ECGs are typically included in surgical bundle billing.

Medical tourism perspective: Patients from the US, UK, or Australia travelling to India, Thailand, or Malaysia for cardiac evaluation can access full 12-lead ECG, echocardiogram, and Holter monitoring as a comprehensive cardiac screening package for $80–$200 total — compared to $500–$1,500 in home countries.

The ECG is rarely used in isolation; it is most powerful when combined with complementary investigations that provide structural, functional, or haemodynamic information the ECG cannot supply.

• Echocardiography (Cardiac Ultrasound): Visualises cardiac chamber size, wall motion, valve function, and pericardial fluid in real time. Essential complement to ECG when left ventricular dysfunction, valvular disease, or pericardial effusion is suspected. No radiation; widely available.
• Cardiac CT Angiography (CCTA): Non-invasive imaging of coronary arteries with sensitivity exceeding 95% for obstructive CAD. Appropriate for intermediate-risk patients with equivocal stress ECG results. Involves radiation and iodinated contrast.
• Nuclear Stress Test (Myocardial Perfusion Imaging): Radionuclide tracers assess regional myocardial blood flow at rest and during pharmacological or exercise stress. Higher sensitivity than exercise ECG alone (85–90%) for detecting significant coronary stenoses.
• Cardiac MRI: Gold standard for characterising myocardial tissue — identifies fibrosis, inflammation (myocarditis), infiltrative diseases, and precise ejection fraction. No radiation but expensive and limited availability.
• Invasive Coronary Angiography: The definitive test for coronary anatomy when revascularisation is being planned. Not used as a screening tool due to its invasive nature; reserved for high-risk presentations or positive non-invasive tests.
• Electrophysiology Study (EPS): An invasive catheter-based procedure to map arrhythmia circuits within the heart when ablation therapy is planned. Used after the ECG identifies a clinically significant arrhythmia requiring curative intervention.

The ECG remains the essential first step — rapid, cheap, and universally available — with complementary tests selected based on the specific diagnostic question it raises.